Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant AAV vectors provides neuroprotection and induces behavioural recovery in a primate model of Parkinson's disease
View/ Open
Author
Eslamboli, A.
Georgievska, B.
Ridley, R. M.
Baker, H. F.
Muzyczka, N.
Burger, C.
Mandel, R. J.
Annett, L.E.
Kirik, D.
Attention
2299/195